All articles by Aninda Chakraborty

UK to double troops in Estonia amid Ukraine crisis

The UK is set to send additional troops to Estonia, amid fears that the Russian military build-up near Ukraine’s border…
Advarra launches new platform to support clinical trials

Advarra has introduced a new platform called SiteIQ to expedite clinical trial start-up by facilitating protocol planning and site selection…
Boehringer Ingelheim and Amgen collaborate on cancer trial

Boehringer Ingelheim and Amgen have entered a clinical phase I collaboration to evaluate a potential combination therapy for cancer. The…
FDA accepts Intellia Therapeutics’ application for leukaemia study

The US Food and Drug Administration (FDA) has accepted Intellia Therapeutics’ investigational new drug (IND) application to assess NTLA-5001 in…
Keen Eye introduces AI-powered platform to support clinical trials

French health tech company Keen Eye has launched a new artificial intelligence (AI) web-based platform to support organisations conducting clinical…

Triall enters partnership to anchor Covid-19 data to blockchain

Dutch start-up Triall has entered a new partnership with local blockchain companies LTO Network and Sphereon to anchor Covid-19 research…
Boehringer and Lilly report positive data from EMPEROR-Preserved trial

Boehringer Ingelheim and Eli Lilly and Company (Lilly) have reported positive data from the EMPEROR-Preserved Phase III trial. The trial…
Anavex reports positive data from Parkinson’s disease dementia study

US-based clinical-stage biopharmaceutical company Anavex Life Sciences has reported positive results from its ANAVEX 2-73 (Blarcamesine) Phase II study for…
Polyphor’s balixafortide fails in late-stage breast cancer study

Swiss biotech Polyphor has reported that its investigational asset, balixafortide, has failed to meet co-primary endpoint in a late-stage breast…
Idorsia starts Phase III study to assess efficacy of heart attack drug

Idorsia has started a Phase III registration study to evaluate the efficacy of experimental drug candidate selatogrel for treating suspected…